CD4 and melanoma: However, studies by two independent groups demonstrated that murine CD4+ T cells specific for TRP-1, upon adoptive transfer into a lymphopenic host, differentiated into cytolytic, IFN-γ secreting effectors [11], [14] that directly killed MHC class II-positive B16 melanoma cells [11].